TRIANA Biomedicines, Inc.
1 clinical trials · Sponsor
◉ Watch TRIANA Biomedicines, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC (NCT07491497) | TRIANA Biomedicines, Inc. | 2026-03-11 |
Track TRIANA Biomedicines, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.